Evaluation of cutaneous manifestations according to the time in renal transplant recipients Renal transplantasyon hastalarinda gözlenen deri bulgularinin süreye göre degişiminin degerlendirilmesi
Turkderm Deri Hastaliklari ve Frengi Arsivi, cilt.47, sa.2, ss.88-93, 2013 (SCI-Expanded, Scopus, TRDizin)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 47 Sayı: 2
- Basım Tarihi: 2013
- Doi Numarası: 10.4274/turkderm.81542
- Dergi Adı: Turkderm Deri Hastaliklari ve Frengi Arsivi
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, TR DİZİN (ULAKBİM)
- Sayfa Sayıları: ss.88-93
- Anahtar Kelimeler: Renal transplantation, immunosuppressant drugs
- Sağlık Bilimleri Üniversitesi Adresli: Evet
Özet
Background and Design: This study is conducted to determine the prevalence and clinical characteristics of cutaneous manifestations in renal transplant patients. Materials and Methods: Hospital records of 116 renal transplant patients were retrospectively investigated. The data obtained from patients who had 6 months follow-up period were evaluated. There were 68 (58.6%) males and 48 (41.4%) females aged between 10 and 68 years (mean=36.6 years). Detailed dermatologic examination was performed. The patients were grouped according to gender (male-female), posttransplant period (1-5 years, 5-10 years, >10 years) and the drugs used (cyclosporin, tacrolimus, other than these two immunosuppressant drugs). Results: The most common cutaneous manifestations were infectious. The dermatological findings were onychomycosis (13), tinea pedis (9), acneiform disorders (15), and warts (9). The clinical evaluation after 6 months has also demonstrated the same result. Among the evaluated patients, 7% showed premalignant or malignant manifestations on clinical examination. According to the results obtained from the patient groups, it was found that gender, length of post-transplant period, and use of immunosuppressant drugs do not influence the clinical manifestations of patients. Conclusion: Dermatologic examinations and long-term follow-up should be performed in renal transplant patients. (Turkderm 2013; 47: 88-93).